Page last updated: 2024-11-03

propiverine and Prostatism

propiverine has been researched along with Prostatism in 1 studies

propiverine: anticholinergic used for overactive bladder syndrome

Prostatism: Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.

Research Excerpts

ExcerptRelevanceReference
"Naftopidil is an alpha-blocker (AB) that has a high affinity for the A1d receptor that may have advantages in treating LUTS in this setting."6.58Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. ( Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R, 2018)
"Naftopidil is an alpha-blocker (AB) that has a high affinity for the A1d receptor that may have advantages in treating LUTS in this setting."2.58Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. ( Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, EC1
Gandhi, S1
Jung, JH1
Imamura, M1
Kim, MH1
Pang, R1
Dahm, P1

Reviews

1 review available for propiverine and Prostatism

ArticleYear
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
    The Cochrane database of systematic reviews, 2018, 10-11, Volume: 10

    Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Uri

2018